Q/C Technologies, Inc.
QCLS- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001321834
No open-market purchases or sales by Q/C Technologies, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.87M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Q/C Technologies, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 12 | 19 | +7 |
| Shares | 16.9K | 752.7K | +735.8K (+4,349.0%) |
| Value | $69.8K | $3.00M | +$2.93M (+4,202.2%) |
New holders (10)
Institutions that held Q/C Technologies, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Private Advisor Group, LLC | 333,826 | $1.33M | 0.01% |
| Quinn Opportunity Partners LLC | 211,390 | $843.4K | 0.04% |
| Vanguard Group Inc | 53,066 | $211.7K | 0.00% |
| Jane Street Group, LLC | 40,486 | $161.5K | 0.00% |
| Virtu Financial LLC | 35,380 | $141.0K | 0.01% |
| Geode Capital Management, LLC | 29,252 | $116.7K | 0.00% |
| Dimensional Fund Advisors LP | 19,058 | $76.0K | 0.00% |
| Engineers Gate Manager LP | 11,333 | $45.2K | 0.00% |
| BNP Paribas Arbitrage, SA | 1,200 | $4.79K | 0.00% |
| Royal Bank of Canada | 4 | $0 | 0.00% |
Sold out (3)
Institutions that held Q/C Technologies, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Fifth Lane Capital, LP | 10,000 | $41.5K |
| Citigroup Inc | 5 | $21 |
| Advisor Group Holdings, Inc. | 99 | $3 |